Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03536741
Other study ID # GIN-TAP 2017
Secondary ID
Status Recruiting
Phase Phase 2
First received
Last updated
Start date October 12, 2017
Est. completion date July 12, 2018

Study information

Verified date May 2018
Source Campus Bio-Medico University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The present study aims to demonstrate the effectiveness of loco-regional wall anesthesia of the transversus abdominis plane block (TAP block) and the rectus sheath block (RS block), compared to intravenous analgesia, in terms of pain reduction, postoperative analgesic drugs consumption, patient satisfaction and decrease of LOS (length of stay), in patients undergoing benign gynecological laparoscopic surgical procedures.


Recruitment information / eligibility

Status Recruiting
Enrollment 70
Est. completion date July 12, 2018
Est. primary completion date July 12, 2018
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- patients undergoing benign laparoscopic gynecological surgery

- age between 18 and 75 years

- BMI >18 e <35

- ECOG Performance Status 0-1

Exclusion Criteria:

- age < 18 or > 75 years

- BMI <18 or > 35

- ECOG Performance Status >1

- Allergy to local anesthetics

- Allergy to NSAIDs

- Chronic kidney failure > II class

- Systemic neoplastic disease actual or previous

- Actual pregnancy

- Active or recent pelvic inflammation

- Persistent coagulopathy

- Previous opioids consumption for chronic pain

- Neurological or cognitive disorders

- Conversion from laparoscopic to open surgery

- Onset of intraoperative complications

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
TAP block and RS block + General Intravenous Anesthestic
transversus abdominis plane block and rectus sheath block
Drug:
General Intravenous Anesthetic
General Intravenous Anesthetic

Locations

Country Name City State
Italy Campus Bio-medico Roma RM

Sponsors (1)

Lead Sponsor Collaborator
Campus Bio-Medico University

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary postoperative pain in the first 72 hours after gynecological surgical procedures postoperative pain in the first 72 hours after gynecological surgical procedures postoperative pain in the first 72 hours after gynecological surgical procedures
Primary analgesic consumption in the first 72 hours after gynecological surgical procedures analgesic consumption in the first 72 hours after gynecological surgical procedures analgesic consumption in the first 72 hours after gynecological surgical procedures